Interest of TTC for the Early Diagnosis of Acute Myocardial Infarction at Autopsy (INFARCTOPSY)

University Hospital Center (CHU)

Status: Unknown

Conditions: Myocardial Infarction

Treatments: Procedure: TTC immersion

Study type: Observational

Funder types: Other

Identifiers

NCT04924426

RECHMPL21_0283

Details and patient eligibility

About

Ischemic heart disease is the leading cause of death worldwide and the leading cause of sudden cardiac death. However, its post-mortem diagnosis is particularly difficult because the gross examination of the heart is usually normal at the autopsy . The diagnosis is therefore often based on a set of indirect arguments, such as the patient's medical and clinical history and the degree of occlusion of the coronary arteries. The formal diagnosis of acute myocardial infarction (AMI) currently relies on standard histological examination. However, histological findings often require a prolonged survival time of several hours to be highlighted. Triphenyltetrazolium chloride (TTC) is a salt that reacts with lactate dehydrogenases contained in still viable myocardial cells, forming a red pigment visible to the naked eye, (1,3,5 triphenylformazan). Ischemia-induced cell death, which occurs within minutes of the causative event, is responsible for the leakage of lactate deshydrogenase into the extracellular medium and thus results in the absence of formazan formation in the infarcted area, which displays an easily identifiable pale unstained color. It has been suggested that the use of TTC would allow the identification of MI as early as one hour of survival in animal models, before the usual macroscopic and microscopic signs are visible. It could therefore represent an attractive forensic tool for the early diagnosis of AMI at the autopsy.

Enrollment: 40 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients autopsied at the Forensic Institute of the CHU of MONTPELLIER whose ante-mortem (medical history, cardiovascular risk factors, clinical history) and autopsy data (significant coronary stenosis associated or not with an endoluminal thrombus, scars of old infarction, absence of other identified cause of death) suggest AMI as the cause of death.
• Known survival time and postmortem interval.

Exclusion criteria

• Putrefied bodies

Trial design

40 participants in 2 patient groups

Patients with AMI

Description:

Patients with AMI

Treatment:

Procedure: TTC immersion

Patients with no AMI

Description:

Patients with no AMI

Treatment:

Procedure: TTC immersion